These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 9825207)
41. Pharmacokinetic evaluation of olopatadine for the treatment of allergic rhinitis and conjunctivitis. Nickels AS; Dimov V; Wolf R Expert Opin Drug Metab Toxicol; 2011 Dec; 7(12):1593-9. PubMed ID: 22032416 [TBL] [Abstract][Full Text] [Related]
42. Besifloxacin ophthalmic suspension 0.6% in patients with bacterial conjunctivitis: A multicenter, prospective, randomized, double-masked, vehicle-controlled, 5-day efficacy and safety study. Karpecki P; Depaolis M; Hunter JA; White EM; Rigel L; Brunner LS; Usner DW; Paterno MR; Comstock TL Clin Ther; 2009 Mar; 31(3):514-26. PubMed ID: 19393842 [TBL] [Abstract][Full Text] [Related]
43. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis. Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR; J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522 [TBL] [Abstract][Full Text] [Related]
44. [Diseases of conjunctiva]. Fechner PU Buch Augenarzt; 1976; 67(0):167-95. PubMed ID: 985718 [No Abstract] [Full Text] [Related]
45. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children. Bowman RJ; Cope J; Nischal KK Eye (Lond); 2004 Jan; 18(1):24-6. PubMed ID: 14707960 [TBL] [Abstract][Full Text] [Related]
47. Diagnosis and management of pediatric conjunctivitis. Teoh DL; Reynolds S Pediatr Emerg Care; 2003 Feb; 19(1):48-55. PubMed ID: 12592117 [No Abstract] [Full Text] [Related]
48. Microbiological etiology and susceptibility of bacterial conjunctivitis isolates from clinical trials with ophthalmic, twice-daily besifloxacin. Haas W; Gearinger LS; Hesje CK; Sanfilippo CM; Morris TW Adv Ther; 2012 May; 29(5):442-55. PubMed ID: 22644963 [TBL] [Abstract][Full Text] [Related]
49. Viral and bacterial conjunctivitis. Prevention of disastrous results. Reed DB Postgrad Med; 1989 Sep; 86(4):103-4, 107-9, 113-4. PubMed ID: 2780435 [TBL] [Abstract][Full Text] [Related]
50. Efficacy and tolerability of besifloxacin ophthalmic suspension 0.6% administered twice daily for 3 days in the treatment of bacterial conjunctivitis: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study in adults and children. Silverstein BE; Allaire C; Bateman KM; Gearinger LS; Morris TW; Comstock TL Clin Ther; 2011 Jan; 33(1):13-26. PubMed ID: 21397770 [TBL] [Abstract][Full Text] [Related]
51. [Conjunctivitis of bacterial origin in children. Local antibiotic treatment with tobramycin collyrium]. Fioretti GM; Campanari C Pediatr Med Chir; 1989; 11(4):421-3. PubMed ID: 2694107 [TBL] [Abstract][Full Text] [Related]
53. [Diagnosis and treatment of conjunctivitis]. Ehlers N; Mabeck CE Nord Med; 1996 Mar; 111(3):74-6, 83. PubMed ID: 8628642 [TBL] [Abstract][Full Text] [Related]
54. [Infectious diseases of newborn infants]. Norman AP Antibiotiki; 1971; 16(8):749-53. PubMed ID: 5003154 [No Abstract] [Full Text] [Related]
55. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: a double-masked, environmental study of patient preference. Leonardi A; Zafirakis P Curr Med Res Opin; 2004 Aug; 20(8):1167-73. PubMed ID: 15324519 [TBL] [Abstract][Full Text] [Related]
59. Efficacy comparison between povidone iodine 2.5% and tetracycline 1% in prevention of ophthalmia neonatorum. David M; Rumelt S; Weintraub Z Ophthalmology; 2011 Jul; 118(7):1454-8. PubMed ID: 21439642 [TBL] [Abstract][Full Text] [Related]
60. Effects of adjuvant therapy with 0.1% olopatadine hydrochloride ophthalmic solution on quality of life in patients with allergic rhinitis using systemic or nasal therapy. Berger W; Abelson MB; Gomes PJ; Beck M; Kimura S; Westbrook T; Storms W; Galant S Ann Allergy Asthma Immunol; 2005 Oct; 95(4):361-71. PubMed ID: 16279567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]